FLGT News and Press, Fulgent Genetics Inc. From 03/15/21

TEMPLE CITY, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a technology company providing comprehensive testing solutions through its scalable platform, today announced that the U.S. Center...

Genetic testing is a hot market right now. But some of the companies involved in genetic testing have very different business models. In this Motley Fool Live video recorded on March 3, 2021 , Fool.com contributors Keith Speights and Brian Orelli address a viewer's question abo...

Investors are buffeted through the Covid testing bonanza and the prospect of these, good for 90%+ of revenues, disappearing, with the tech selloff to boot. This explains the extreme volatility of the shares as perspectives constantly change. However, cutting through the fog it's i...

Fulgent Genetics' share price has collapsed as the short squeeze bubble has moved on. Fulgent released a fantastic quarterly report in early March. The future remains somewhat hard to visualize, but we are getting closer to arriving at a decent price for Fulgent. For further...

Can a diagnostics company that makes most of its money from coronavirus tests keep growing in a post-pandemic environment? Fulgent Genetics (NASDAQ: FLGT) shares are still far below their peak in February, despite reporting record revenue in the fourth quarter. Could this st...

4 Health Care Stocks To Consider Buying In March Health care is one of the most important sectors in the world today. They are one of the largest and most complex sectors, with a broad range of companies that sell medical products and services. Investors are watching the health care...

Shares of Fulgent Genetics (NASDAQ: FLGT) soared nearly 31% at one point Friday morning. However, the stock was up only 5% as of 11 a.m. EST. That huge, albeit temporary, gain stemmed from Fulgent's fourth-quarter update after the market close on Thursday. The genetic testin...

XTL Biopharmaceuticals (XTLB) +93%.Second Sight Medical Products, Inc. (EYES) +50%.Fulgent Genetics, Inc. (FLGT) +32% on Q4 results.CLPS Incorporation (CLPS) +29% on FQ2 results.Sify Technologies Limited (SIFY) +26% on report of Blackstone buying minority stake.Waitr Holdings (...

TEMPLE CITY, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that its ...

Fulgent Genetics (FLGT) has risen ~27.4% in the premarket after a sizable beat in the Q4 2020 earnings.2020 revenue has increased ~13.0x from the previous year to reach ~$421.7M after the quarterly revenue rose ~35.2x to ~$295.0M. However, non-COVID revenue for Q4 2020 has rise...